| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 1,969,100 | 1,926,200 | 1,585,600 | 1,732,800 | | Cost of Revenue | 1,609,700 | 1,593,200 | 1,312,500 | 1,484,300 | | | Gross Profit | 359,400 | 333,000 | 273,100 | 248,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 97,500 | 62,200 | 80,200 | 60,600 | | Non Recurring | 46,800 |
-
|
-
| 31,500 | | Others | 70,400 | 69,400 | 66,700 | 72,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 179,500 | 201,400 | 126,200 | 83,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34,800 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 179,500 | 201,400 | 126,200 | (20,300) | | Interest Expense | 28,900 | 24,700 | 25,800 | 33,700 | | Income Before Tax | 150,600 | 176,700 | 100,400 | (54,000) | | Income Tax Expense | 52,300 | 48,400 | 28,100 | 19,000 | | Minority Interest | (400) |
-
|
-
| (100) | | | | Net Income From Continuing Ops | 103,400 | 133,500 | 69,600 | 33,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 103,400 | 133,500 | 69,600 | 33,800 | | Preferred Stock And Other Adjustments | 300 | (200) | (100) |
-
| | | Net Income Applicable To Common Shares | $103,700 | $133,300 | $69,500 | $33,800 |
|
0.51% Nasdaq 
Income Statement
